Evidence map›Paper›PMID 32196547›Full record

ArticleHuman molecular genetics2020

Novel truncating mutations in CTNND1 cause a dominant craniofacial and cardiac syndrome.

Reham Alharatani, Athina Ververi, Ana Beleza-Meireles, Weizhen Ji, Emily Mis, Quinten T Patterson, John N Griffin, Nabina Bhujel, Caitlin A Chang, Abhijit Dixit and 20 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Functional analysis ofbioRxiv : the preprint server for biology · 2024
    Article
  8. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 4 countries.

Reham AlharataniCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Athina VerveriDepartment of Clinical Genetics, Great Ormond Street Hospital Trust, London WC1N 3JH, UK.
Ana Beleza-MeirelesCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Weizhen JiPediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Emily MisPediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Quinten T PattersonDepartments of Internal Medicine and Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856, USA.
John N GriffinCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Nabina BhujelSouth Thames Cleft Service, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
Caitlin A ChangDepartment of Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, AB, Canada.
Abhijit DixitNottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.
Monica KonstantinoPediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Christopher HealyCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Sumayyah HannanCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Natsuko NeoCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
Alex CashSouth Thames Cleft Service, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
Dong LiCenter for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Elizabeth BhojDepartment of Pediatrics, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Elaine H ZackaiDepartment of Pediatrics, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Ruth CleaverPeninsula Clinical Genetics Service, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Diana BaralleHuman Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Meriel McEntagartDepartment of Clinical Genetics, St George's Hospital, London SW17 0RE, UK.
Ruth Newbury-EcobClinical Genetics, University Hospital Bristol NHS Foundation Trust, Bristol BS2 8EG, UK.
Richard ScottDepartment of Clinical Genetics, Great Ormond Street Hospital Trust, London WC1N 3JH, UK.
Jane A HurstDepartment of Clinical Genetics, Great Ormond Street Hospital Trust, London WC1N 3JH, UK.
Ping Yee Billie AuDepartment of Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, AB, Canada.
Marie Therese HoseyPaediatric Dentistry, Centre of Oral, Clinical and Translational Science, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE5 9RS, UK.
Mustafa KhokhaPediatric Genomics Discovery Program, Departments of Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Denise K MarcianoDepartments of Internal Medicine and Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856, USA.
Saquib A LakhaniPediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Karen J LiuCentre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK.
King's College London · GBYale University · USChildren's Hospital of Philadelphia · USGreat Ormond Street Hospital · GBGuy's and St Thomas' NHS Foundation Trust · GBThe University of Texas Southwestern Medical Center · USUniversity of Calgary · CANottingham University Hospitals NHS Trust · GBRoyal Devon & Exeter NHS Foundation Trust · GBSt George's Hospital · GBTokyo Medical and Dental University · JPUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity of Southampton · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Role of afadin signaling in nephron tubulogenesisR01DK099478 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MARCIANO, DENISE K · 2014 to 2018
$1.7M
Biotechnology and Biological Sciences Research Council BB/R015953/1British Heart FoundationDepartment of Health HICF-1009-003Medical Research CouncilNCATS NIH HHS UL1 TR001863NIDDK NIH HHS R01 DK099478Wellcome TrustWellcome Trust 099175/Z/12/Z
6 · The paper itself

Abstract

CTNND1 encodes the p120-catenin (p120) protein, which has a wide range of functions, including the maintenance of cell-cell junctions, regulation of the epithelial-mesenchymal transition and transcriptional signalling. Due to advances in next-generation sequencing, CTNND1 has been implicated in human diseases including cleft palate and blepharocheilodontic (BCD) syndrome albeit only recently. In this study, we identify eight novel protein-truncating variants, six de novo, in 13 participants from nine families presenting with craniofacial dysmorphisms including cleft palate and hypodontia, as well as congenital cardiac anomalies, limb dysmorphologies and neurodevelopmental disorders. Using conditional deletions in mice as well as CRISPR/Cas9 approaches to target CTNND1 in Xenopus, we identified a subset of phenotypes that can be linked to p120-catenin in epithelial integrity and turnover, and additional phenotypes that suggest mesenchymal roles of CTNND1. We propose that CTNND1 variants have a wider developmental role than previously described and that variations in this gene underlie not only cleft palate and BCD but may be expanded to a broader velocardiofacial-like syndrome.

Indexed as

AdolescentAdultAnimalsAnodontiaCateninsChildChild, PreschoolCleft LipCleft PalateCraniofacial AbnormalitiesDelta CateninDisease Models, AnimalEctropionFemaleGenetic Predisposition to DiseaseHeart Defects, CongenitalCateninsDelta Catenin

Identifiers

PMID32196547
PMCPMC7372553
OpenAlexW3012087764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.